C ion-implanted TiO2 thin film for photocatalytic applications

Third-generation TiO2 photocatalysts were prepared by implantation of C+ ions into 110 nm thick TiO2 films. An accurate structural investigation was performed by Rutherford backscattering spectrometry, secondary ion mass spectrometry, X-ray diffraction, Raman-luminescence spectroscopy, and UV/VIS optical characterization. The C doping locally modified the TiO2 pure films, lowering the band-gap energy from 3.3 eV to a value of 1.8 eV, making the material sensitive to visible light. The synthesized materials are photocatalytically active in the degradation of organic compounds in water under both UV and visible light irradiation, without the help of any additional thermal treatment. These results increase the understanding of the C-doped titanium dioxide, helpful for future environmental applications. (C) 2015 AIP Publishing LLC

First optical validation of a Schwarzschild Couder telescope: the ASTRI SST-2M Cherenkov telescope

The Cherenkov Telescope Array (CTA) represents the most advanced facility designed for Cherenkov Astronomy. ASTRI SST-2M has been developed as a demonstrator for the Small Size Telescope in the context of the upcoming CTA. Its main innovation consists in the optical layout which implements the Schwarzschild-Couder configuration and is fully validated for the first time. The ASTRI SST-2M optical system represents the first qualified example for two mirrors telescope for Cherenkov Astronomy. This configuration permits to (i) maintain a high optical quality across a large FoV (ii) de-magnify the plate scale, (iii) exploit new technological solutions for focal plane sensors. The goal of the paper is to present the optical qualification of the ASTRI SST-2M telescope. The qualification has been obtained measuring the PSF sizes generated in the focal plane at various distance from the optical axis. These values have been compared with the performances expected by design. After an introduction on the Gamma Astronomy from the ground, the optical design and how it has been implemented for ASTRI SST-2M is discussed. Moreover the description of the setup used to qualify the telescope over the full field of view is shown. We report the results of the first--light optical qualification. The required specification of a flat PSF of $\sim 10$ arcmin in a large field of view ~10 deg has been demonstrated. These results validate the design specifications, opening a new scenario for Cherenkov Gamma ray Astronomy and, in particular, for the detection of high energy (5 - 300 TeV) gamma rays and wide-field observations with CTA.Comment: 6 pages, 5 figure

Radio emission from the high-mass X-ray binary BP Cru: first detection

BP Cru is a well known high-mass X-ray binary composed of a late B hypergiant (Wray 977) and a neutron star, also observed as the X-ray pulsar GX 301-2. No information about emission from BP Cru in other bands than X-rays and optical has been reported to date in the literature, though massive X-ray binaries containing black holes can have radio emission from a jet. In order to assess the presence of a radio jet, we searched for radio emission towards BP Cru using the Australia Compact Array Telescope during a survey for radio emission from Be/X-ray transients. We probed the 41.5d orbit of BP Cru with the Australia Telescope Compact Array not only close to periastron but also close to apastron. BP Cru was clearly detected in our data on 4, possibly 6, of 12 occasions at 4.8 and 8.6 GHz. Our data suggest that the spectral index of the radio emission is modulated either by the X-ray flux or the orbital phase of the system. We propose that the radio emission of BP Cru probably arises from two components: a persistent component, coming from the mass donor Wray 977, and a periodic component connected to the accretion onto the neutron star, possibly coming from a (weak and short lived) jet.Comment: 2 figures, accepted for publication in A+A letter

Isolated, Massive Supergiants near the Galactic Center

We have carried out a pilot project to assess the feasibility of using radio, infrared, and X-ray emission to identify young, massive stars located between 1 and 25 pc from the Galactic center. We first compared catalogs compiled from the Very Large Array, the Chandra X-ray Observatory, and 2MASS. We identified two massive, young stars: the previously-identified star that is associated with the radio HII region H2, and a newly-identified star that we refer to as CXOGC J174516.1-290315. The infrared spectra of both stars exhibit very strong Br-gamma and He I lines, and resemble those of massive supergiants that have evolved off of the main sequence, but not yet reached the Wolf-Rayet phase. We estimate that each star has a bolometric luminosity >10^6 L_sun. The detection of these two sources in X-rays is surprising, because stars at similar evolutionary states are not uniformly bright X-ray sources. Therefore, we suggest that both stars are in binary systems that contain either OB stars whose winds collide with those of the luminous supergiants, or compact objects that are accreting from the winds of the supergiants. We also identify X-ray emission from a nitrogen-type Wolf-Rayet star and place upper limits on the X-ray luminosities of three more evolved, massive stars that previously have been identified between 1 and 25 pc from Sgr A*. Finally, we briefly discuss the implications that future searches for young stars will have for our understanding of the recent history of star formation near the Galactic center. (abridged)Comment: 9 pages, including 8 figures. Submitted to ApJ, and modified in response to referee's repor

Sustainability in Aquaponics: Industrial Spirulina Waste as a Biofertilizer for Lactuca sativa L. Plants

Aquaponics represents an alternative to traditional soil cultivation. To solve the problem of nutrient depletion that occurs in this biotechnological system, the application of a spirulina-based biofertilizer was assessed. The microalgal waste used in this study came from industrial processing. Four different dilutions of the supernatant portion of this waste were sprayed on lettuce plants cultivated in an aquaponics system installed at the Botanical Gardens of the Tor Vergata University of Rome. The biofertilizer was characterized to evaluate its amount of macro- and micronutrients. The analysis conducted on the plants involved both morpho-biometric aspects and qualitative–quantitative measurements. The experiments showed that the spirulina extract had a positive effect on the growth and nutraceutical content of the lettuce plants; the obtained results highlighted that a dilution of 75% was the best for treatment. The use of the proposed organic and recycled fertilizer could increase the sustainability of crop cultivation and promote the functioning of aquaponics systems

The Discordance of Mass-Loss Estimates for Galactic O-Type Stars

We have determined accurate values of the product of the mass-loss rate and the ion fraction of P^{4+}, Mdot q(P^{4+}), for a sample of 40 Galactic O-type stars by fitting stellar-wind profiles to observations of the P V resonance doublet obtained with FUSE, ORFEUS/BEFS, and Copernicus. When P^{4+} is the dominant ion in the wind, Mdot q(P^{4+}) approximates the mass-loss rate to within a factor of 2. Theory predicts that P^{4+} is the dominant ion in the winds of O7-O9.7 stars, though an empirical estimator suggests that the range from O4-O7 may be more appropriate. However, we find that the mass-loss rates obtained from P V wind profiles are systematically smaller than those obtained from fits to Halpha emission profiles or radio free-free emission by median factors of about 130 (if P^{4+} is dominant between O7 and O9.7) or about 20 (if P^{4+} is dominant between O4 and O7). These discordant measurements can be reconciled if the winds of O stars in the relevant temperature range are strongly clumped on small spatial scales. We use a simplified two-component model to investigate the volume filling factors of the denser regions. This clumping implies that mass-loss rates determined from "density squared" diagnostics have been systematically over-estimated by factors of 10 or more, at least for a subset of O stars. Reductions in the mass-loss rates of this size have important implications for the evolution of massive stars and quantitative estimates of the feedback that hot-star winds provide to their interstellar environments.Comment: 26 pages, 4 figures; accepted for publication in Ap

Intra-arterial administration of recombinant tissue-type plasminogen activator (rt-PA) causes more intracranial bleeding than does intravenous rt-PA in a transient rat middle cerebral artery occlusion model

<p>Abstract</p> <p>Background</p> <p>Intra-arterial (IA) administration of rt-PA for ischemic stroke has the potential for greater thrombolytic efficacy, especially for a large thrombus in the M1 or M2 segment of the middle cerebral artery (MCA). Intracranial hemorrhage (ICH) is a concern with IA or intravenous (IV) administration especially as the therapeutic window is extended. However, because IA administration delivers a higher local concentration of agent, the incidence and severity of ICH may be greater than with similar doses IV. We investigated the safety of rt-PA administration by IA compared to IV infusion following 6 hours of MCA occlusion (MCAo) with reflow in the spontaneously hypertensive rat (SHR).</p> <p>Methods</p> <p>Male SHRs were subjected to 6 hours MCAo with 18 hours reflow using a snare ligature model. They were treated with IA saline, IA rt-PA (1, 5, 10, 30 mg/kg), or IV rt-PA (10 and 30 mg/kg) by a 10 to 60 minute infusion beginning approximately 1 minute before reflow. The rats were recovered for 24 hours after MCAo onset at which time Bleeding Score, infarct volume, and Modified Bederson Score were measured.</p> <p>Results</p> <p>Greater hemorrhagic transformation occurred with 10 and 30 mg/kg rt-PA administered IA than IV. The IV 10 mg/kg rt-PA dosage induced significantly less bleeding than did the 1 or 5 mg/kg IA groups. No significant increase in infarct volume was observed after IA or IV treatment. Rats treated with 30 mg/kg rt-PA by either the IA or IV route had greater neurological dysfunction compared to all other groups.</p> <p>Conclusions</p> <p>Administration of rt-PA by the IA route following 6 hours of MCAo results in greater ICH and worse functional recovery than comparable dosages IV. Significantly greater bleeding was observed when the IA dose was a tenth of the IV dose. The increased bleeding did not translate in larger infarct volumes.</p

Ultramicronized palmitoylethanolamide rescues learning and memory impairments in a triple transgenic mouse model of Alzheimer's disease by exerting anti-inflammatory and neuroprotective effects

In an aging society, Alzheimer’s disease (AD) exerts an increasingly serious health and economic burden. Current treatments provide inadequate symptomatic relief as several distinct pathological processes are thought to underlie the decline of cognitive and neural function seen in AD. This suggests that the efficacy of treatment requires a multitargeted approach. In this context, palmitoylethanolamide (PEA) provides a novel potential adjunct therapy that can be incorporated into a multitargeted treatment strategy. We used young (6-month-old) and adult (12-month-old) 3×Tg-AD mice that received ultramicronized PEA (um-PEA) for 3 months via a subcutaneous delivery system. Mice were tested with a range of cognitive and noncognitive tasks, scanned with magnetic resonance imaging/magnetic resonance spectroscopy (MRI/MRS), and neurochemical release was assessed by microdialysis. Potential neuropathological mechanisms were assessed postmortem by western blot, reverse transcription–polymerase chain reaction (RT-PCR), and immunofluorescence. Our data demonstrate that um-PEA improves learning and memory, and ameliorates both the depressive and anhedonia-like phenotype of 3×Tg-AD mice. Moreover, it reduces Aβ formation, the phosphorylation of tau proteins, and promotes neuronal survival in the CA1 subregion of the hippocampus. Finally, um-PEA normalizes astrocytic function, rebalances glutamatergic transmission, and restrains neuroinflammation. The efficacy of um-PEA is particularly potent in younger mice, suggesting its potential as an early treatment. These data demonstrate that um-PEA is a novel and effective promising treatment for AD with the potential to be integrated into a multitargeted treatment strategy in combination with other drugs. Um-PEA is already registered for human use. This, in combination with our data, suggests the potential to rapidly proceed to clinical use